HU166989B - - Google Patents

Info

Publication number
HU166989B
HU166989B HUEI419A HUEI000419A HU166989B HU 166989 B HU166989 B HU 166989B HU EI419 A HUEI419 A HU EI419A HU EI000419 A HUEI000419 A HU EI000419A HU 166989 B HU166989 B HU 166989B
Authority
HU
Hungary
Application number
HUEI419A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU166989B publication Critical patent/HU166989B/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HUEI419A 1971-04-30 1972-04-28 HU166989B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13912071A 1971-04-30 1971-04-30

Publications (1)

Publication Number Publication Date
HU166989B true HU166989B (en:Method) 1975-07-28

Family

ID=22485216

Family Applications (1)

Application Number Title Priority Date Filing Date
HUEI419A HU166989B (en:Method) 1971-04-30 1972-04-28

Country Status (23)

Country Link
US (1) US3758683A (en:Method)
JP (1) JPS5735185B1 (en:Method)
BE (1) BE782651A (en:Method)
CA (1) CA976085A (en:Method)
CH (1) CH566784A5 (en:Method)
CS (1) CS209458B2 (en:Method)
DD (1) DD100708A5 (en:Method)
DE (1) DE2219635C3 (en:Method)
DK (1) DK131760C (en:Method)
ES (1) ES402176A1 (en:Method)
FI (1) FI49773C (en:Method)
FR (1) FR2134658B1 (en:Method)
GB (1) GB1385086A (en:Method)
HU (1) HU166989B (en:Method)
IL (1) IL39181A (en:Method)
NL (1) NL178258C (en:Method)
NO (1) NO137178C (en:Method)
PL (1) PL86966B1 (en:Method)
RO (1) RO64387A (en:Method)
SE (1) SE378066B (en:Method)
SU (1) SU508162A3 (en:Method)
YU (1) YU36155B (en:Method)
ZA (1) ZA722243B (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140801B (da) * 1975-01-15 1979-11-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.
NL193099C (nl) * 1981-10-30 1998-11-03 Novo Industri As Gestabiliseerde insuline-oplossing.
JPH01501389A (ja) * 1986-10-20 1989-05-18 ノボ インダストリ アクティーゼルスカブ ポリペプチド製剤
EP0280534B1 (en) * 1987-02-25 1993-04-21 Novo Nordisk A/S Novel insulin derivatives
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
US6624141B1 (en) * 1999-03-17 2003-09-23 The Regents Of The University Of Michigan Protamine fragment compositions and methods of use
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
MX344293B (es) 2008-10-17 2016-12-13 Sanofi Aventis Deutschland Combinacion de una insulina y un agonista de glp-1.
WO2011058083A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten, ein insulin und methionin
MX2012005184A (es) 2009-11-13 2012-06-08 Sanofi Aventis Deutschland Composicion farmaceutica que comprende un agonista de glp-1 y metionina.
US20140148384A1 (en) 2010-08-30 2014-05-29 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
SI2750699T1 (sl) 2011-08-29 2015-11-30 Sanofi-Aventis Deutschland Gmbh Farmacevtska kombinacija, za uporabo pri glikemični kontroli pri pacientih, ki imajo sladkorno bolezen tipa 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
JP6970615B2 (ja) 2014-12-12 2021-11-24 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング インスリングラルギン/リキシセナチド固定比処方
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
CN111050750B (zh) 2017-08-24 2024-09-24 诺和诺德股份有限公司 Glp-1组合物及其用途
US20230082544A1 (en) 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5038E (fr) * 1904-03-09 1905-12-02 Georges Frederic Brade Perfectionnements dans la fabrication des organes du métronome
GB889769A (en) * 1957-07-18 1962-02-21 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form

Also Published As

Publication number Publication date
RO64387A (fr) 1979-07-15
BE782651A (fr) 1972-10-26
PL86966B1 (en:Method) 1976-06-30
CH566784A5 (en:Method) 1975-09-30
NL178258B (nl) 1985-09-16
DD100708A5 (en:Method) 1973-10-05
NO137178B (no) 1977-10-10
DK131760B (da) 1975-09-01
SU508162A3 (ru) 1976-03-25
DK131760C (da) 1976-02-02
GB1385086A (en) 1975-02-26
FI49773C (fi) 1975-10-10
ZA722243B (en) 1973-11-28
DE2219635A1 (de) 1972-11-09
IL39181A0 (en) 1972-06-28
JPS5735185B1 (en:Method) 1982-07-27
FI49773B (en:Method) 1975-06-30
FR2134658B1 (en:Method) 1975-10-17
SE378066B (en:Method) 1975-08-18
CS209458B2 (en) 1981-12-31
YU36155B (en) 1982-02-25
NL178258C (nl) 1986-02-17
US3758683A (en) 1973-09-11
CA976085A (en) 1975-10-14
ES402176A1 (es) 1975-03-01
IL39181A (en) 1974-09-10
NO137178C (no) 1978-01-18
FR2134658A1 (en:Method) 1972-12-08
NL7205865A (en:Method) 1972-11-01
DE2219635C3 (de) 1981-10-15
DE2219635B2 (de) 1980-11-27
YU114272A (en) 1981-06-30

Similar Documents

Publication Publication Date Title
CS154346B2 (en:Method)
CS156787B1 (en:Method)
CS155926B1 (en:Method)
CS155923B1 (en:Method)
CS157897B1 (en:Method)
CS157775B1 (en:Method)
CS159913B1 (en:Method)
CS156652B1 (en:Method)
CS149153B1 (en:Method)
CS159408B1 (en:Method)
CS154150B1 (en:Method)
CS154074B1 (en:Method)
CS155721B1 (en:Method)
CS152635B1 (en:Method)
CS150873B1 (en:Method)
CS150781B1 (en:Method)
CS150433B1 (en:Method)
CS150340B1 (en:Method)
CH546429A (en:Method)
CH568494A5 (en:Method)
CH574927A5 (en:Method)
CH575456A5 (en:Method)
CH580629A5 (en:Method)
CH583331B5 (en:Method)
CH587204A5 (en:Method)